VIX
43
8
CB
61
3
DG
68
-10
CTAS
28
-8
KSS
59
-3
CF
44
2
A
44
-3
MAT
50
-4
GILD
47
-9
LB
33
-7
ETN
67
2
MET
58
-2
ZBH
45
-2
NVDA
54
2
ACN
52
2
FTI
64
-15
O
50
-7
EFX
44
-3
CAT
73
-3
LOW
46
-16
VIX
43
8
CB
61
3
DG
68
-10
CTAS
28
-8
KSS
59
-3
CF
44
2
A
44
-3
MAT
50
-4
GILD
47
-9
LB
33
-7
ETN
67
2
MET
58
-2
ZBH
45
-2
NVDA
54
2
ACN
52
2
FTI
64
-15
O
50
-7
EFX
44
-3
CAT
73
-3
LOW
46
-16
Financhill
Back

Brookfield Infrastructure Partners LP Vs. Arrowhead Pharmaceuticals, Inc. Industry Stock Comparison

Sell
36

BIP.UN.TO
Brookfield Infrastructure Partners LP

Last Price:
$48.82
Seasonality Move:
4.38%
Sell
50

ARWR
Arrowhead Pharmaceuticals, Inc.

Last Price:
$68.58
Seasonality Move:
40.49%
Sell
36
Brookfield Infrastructure Partners LP (BIP.UN.TO) is a Sell

Is Brookfield Infrastructure Partners LP a Buy, Sell or Hold?

  • The current Brookfield Infrastructure Partners LP [BIP.UN.TO] share price is $48.82. The Score for BIP.UN.TO is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • BIP.UN.TO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Arrowhead Pharmaceuticals, Inc. (ARWR) is a Sell

Is Arrowhead Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Arrowhead Pharmaceuticals, Inc. [ARWR] share price is $68.60. The Score for ARWR is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • ARWR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BIP.UN.TO Stock Price Chart

What is Brookfield Infrastructure Partners LP's stock price today?

ARWR Stock Price Chart

What is Arrowhead Pharmaceuticals, Inc.'s stock price today?

  • The Arrowhead Pharmaceuticals, Inc. share price today is $68.60
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARWR is experiencing slight buying pressure.

BIP.UN.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.35 Buy
Relative Strength Index (14 RSI): 44.73 Sell
Chaikin Money Flow: 75922 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (48.99 - 50.35) Sell
Bollinger Bands (100): (42.63 - 48.93) Buy

ARWR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.94 Buy
Relative Strength Index (14 RSI): 75.92 Buy
Chaikin Money Flow: 249389 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (37.15 - 56.87) Buy
Bollinger Bands (100): (20.01 - 44.73) Buy

BIP.UN.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 49.97 Sell
20-day SMA: 49.85 Sell
50-day SMA: 48.74 Buy
200-day SMA: 44.61 Buy
8-day EMA: 49.73 Sell
20-day EMA: 49.62 Sell
50-day EMA: 48.42 Buy
200-day EMA: 45.75 Buy

ARWR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 60.55 Buy
20-day SMA: 48.94 Buy
50-day SMA: 42.23 Buy
200-day SMA: 23.8 Buy
8-day EMA: 60.08 Buy
20-day EMA: 52.14 Buy
50-day EMA: 43.49 Buy
200-day EMA: 29.21 Buy

Brookfield Infrastructure Partners LP Earnings Growth & BIP.UN.TO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.10 per share, and an increase next year of $0.68 per share.

Arrowhead Pharmaceuticals, Inc. Earnings Growth & ARWR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.49 per share, and a decrease next year of $3.13 per share.

Brookfield Infrastructure Partners LP Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Arrowhead Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):